Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Health care professional (HCP) and patient digital expectations demand human and AI collaboration, innovation and experimentation. Technological agility is the key to providing Medical Information (MI) in this digital era. Largely accelerated by the pandemic, HCPs and patients are quickly adapting to self-serve digital methods for MI, but still want the ability to engage with human experts as necessary. Artificial intelligence (AI), particularly conversational AI, is being utilized in complementary ways with human experts as companies strive to handle not only the volume of MI inquiries but the increasing number of ‘off-hours’ requests as well. As the pandemic continues, HCP and patient expectations for digital access to MI are increasing at a rapid rate.
To not only improve, but deepen customer relationships and engagement, companies need to satisfy customers’ needs for MI quickly and seamlessly. This podcast will highlight some of the key strategies MI teams should look to embrace to strategically approach expanding capabilities through AI/human hybrid models.
Director, Medical Information and Marketed Product Safety
IQVIA
Simon Johns has over 23 years of experience managing customer projects across all stages of drug development and the product lifecycle. As Director of Medical Information (MI) and Marketed Product Safety, he has been managing global MI projects focused on process optimization and technology enablement that drive enhanced efficiency and customer engagement. Simon is a member of the European DIA Medical Information and Communications Training Team, advising pharmaceutical companies on best industry practices, innovation and automation. He speaks regularly on topics ranging from the benefits of integrating pharmacovigilance and MI to increase compliance and product value to recent PV changes and challenges in Emerging Markets such as Russia and ex-Soviet countries.
Chief Customer Officer
conversationHEALTH
Richard is a C-level executive with 20 years of building brands and businesses in startup and multinational organizations, both in North America and globally. Prior to conversationHEALTH, Richard led a North American strategy agency focused on brand innovation and digital transformation, working with companies like Salesforce and Alphabet. At heart, however, Richard is an industry insider. He was a founding executive at Silicon Valley-based biotech companies and prior to that held a number of leadership roles across Johnson & Johnson businesses.
Custom Content Writer
Informa Pharma Intelligence
